Connection
Barry Uretsky to Cardiovascular Agents
This is a "connection" page, showing publications Barry Uretsky has written about Cardiovascular Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.879 |
|
|
|
-
Uretsky BF. Treating the left main bifurcation lesion: the "three stent solution". Catheter Cardiovasc Interv. 2009 Jan 01; 73(1):42-3.
Score: 0.319
-
Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol. 2004 Oct 06; 44(7):1343-53.
Score: 0.238
-
Osman A, Otero J, Brizolara A, Waxman S, Stouffer G, Fitzgerald P, Uretsky BF. Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes. Am Heart J. 2004 May; 147(5):e23.
Score: 0.231
-
Merla R, Daher IN, Ye Y, Uretsky BF, Birnbaum Y. Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms. Am Heart J. 2007 Aug; 154(2):391-402.
Score: 0.072
-
Wang FW, Uretsky BF, Freeman JL, Zhang D, Giordano SH, Goodwin JS. Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual? Catheter Cardiovasc Interv. 2008 Apr 01; 71(5):636-43.
Score: 0.019